Which diet is best for long-term weight loss?

No single named diet is best. A network meta-analysis of 14 diets found that differences in weight loss largely disappeared by 12 months as adherence declined. The strongest predictor of outcome is personal preference and adherence capacity, so the best diet is whichever eating pattern you can maintain long-term while creating a modest calorie deficit.

Does exercise alone cause significant weight loss?

Exercise alone typically produces only modest weight loss — about 1–3 kg over several months — partly because people often eat more or move less outside structured sessions. However, high levels of physical activity are one of the strongest behavioral predictors of keeping weight off long-term, making exercise especially valuable for maintenance rather than initial loss.

How does sleep affect weight loss?

Short sleep duration (fewer than six hours per night) is associated with significantly increased obesity risk. Sleep deprivation raises ghrelin, a hunger-stimulating hormone, and lowers leptin, a satiety hormone, directly disrupting appetite regulation. The article describes targeting seven to nine hours per night as a metabolic intervention, not just a lifestyle preference.

Do GLP-1 medications like semaglutide really work for weight loss?

FDA-approved semaglutide (Wegovy) produced a mean weight loss of approximately 14.9% of body weight over 68 weeks in a large phase 3 trial, compared to 2.4% with placebo. However, roughly two-thirds of lost weight is typically regained within a year of stopping the medication, and side effects lead some patients to discontinue. These medications work best combined with lifestyle changes.

What behavioral strategies actually help with weight loss?

Self-monitoring is among the most evidence-supported single behaviors — tracking food intake consistently correlates with greater weight loss regardless of method used. Structured programs that also include goal-setting, problem-solving for high-risk situations, and ongoing contact with a coach or clinician consistently outperform diet or exercise interventions alone.

What Actually Works for Sustainable Weight Loss, According to Evidence

Sustainable weight loss is less about finding the "right" diet and more about finding an eating pattern and activity level you can maintain for years, not weeks (Sacks et al., 2009).
Weight regain after dieting is common and driven partly by biology — hormonal and metabolic adaptations that increase hunger and lower energy expenditure after weight loss (Sumithran et al., 2011; Fothergill et al., 2016).
Behavioral strategies — regular self-monitoring, structured meal planning, and ongoing support — are consistently linked to better long-term outcomes than any specific macronutrient ratio (Wing & Phelan, 2005; Look AHEAD Research Group, 2014).
Modest, gradual weight loss (5–10% of body weight) produces meaningful health benefits and is more achievable to sustain than aggressive rapid-loss approaches (Wing et al., 2011).
FDA-approved medications like semaglutide and tirzepatide can help some people, but they work best alongside — not instead of — lifestyle changes, and should be prescribed and monitored by a clinician (Wilding et al., 2021; Jastreboff et al., 2022).

Why "just eat less and move more" isn't the whole story

It's true that weight loss requires a sustained energy deficit — that part of the equation hasn't changed. But the harder question is why that deficit is so difficult to maintain over time. Research on weight regulation shows the body actively resists weight loss through coordinated hormonal changes. In a landmark study, Sumithran et al. (2011) found that a year after significant weight loss, participants had elevated levels of hunger-promoting hormones like ghrelin and reduced levels of satiety hormones — changes that persisted long after the initial diet ended. This helps explain why willpower alone often isn't enough.

A separate study of "Biggest Loser" contestants found that resting metabolic rate remained suppressed for years after dramatic weight loss, even as most participants regained weight (Fothergill et al., 2016). The takeaway isn't that weight loss is futile — it's that maintenance requires ongoing strategy, not a finish line mentality. Sustainable weight loss plans account for these biological pressures rather than ignoring them.

Does the type of diet matter?

There's a persistent belief that some diets — low-carb, low-fat, keto, intermittent fasting — are inherently superior for fat loss. The evidence doesn't strongly support this. In one of the more rigorous head-to-head comparisons, Sacks et al. (2009) randomized over 800 adults to diets with different fat, protein, and carbohydrate compositions and found essentially the same weight loss at two years across all groups. What mattered more was adherence — people who attended more support sessions and stuck with their assigned diet longest lost the most weight, regardless of which diet they were assigned.

A similar pattern showed up in the DIETFITS trial, which compared healthy low-fat versus healthy low-carbohydrate diets in over 600 adults: average weight loss was nearly identical between groups at 12 months (Gardner et al., 2018). Genetic and insulin-secretion markers that researchers hypothesized might predict which diet worked better for whom did not meaningfully do so.

This doesn't mean all diets are equally healthy for every purpose — someone with type 2 diabetes may benefit from a lower-carbohydrate approach for glycemic control, for instance. But for the specific goal of sustainable weight loss, the research suggests the best diet is the one a person can realistically follow long-term, built around whole foods, adequate protein, and appropriate portions.

The behavioral habits linked to long-term success

The National Weight Control Registry, which has tracked thousands of people who lost significant weight and kept it off for years, offers some of the most useful real-world data available. Common habits among long-term maintainers include eating breakfast regularly, weighing themselves at least weekly, keeping physical activity high (often 200+ minutes per week), and limiting screen/TV time (Wing & Phelan, 2005). None of these behaviors is exotic, but the consistency matters more than the specifics.

Self-monitoring in particular shows up again and again in the literature as one of the stronger predictors of success. In a study of nearly 1,700 adults, more frequent self-weighing and food journaling were associated with greater weight loss over six months (Wing et al., 2011). Structured programs that build in regular check-ins, whether with a coach, clinician, or app, tend to outperform unstructured "just try harder" approaches.

The Look AHEAD trial, a large long-term study of adults with type 2 diabetes, is instructive too. Participants assigned to an intensive lifestyle intervention (diet plus exercise counseling) achieved and maintained greater weight loss than a control group over more than 8 years — though weight loss did plateau and partially reverse over time, reinforcing that maintenance is an ongoing process rather than a one-time achievement (Look AHEAD Research Group, 2014).

How much weight loss is actually meaningful?

Marketing around weight loss often implies that more is always better, but the clinical research points to a more modest and realistic target. A loss of just 5–10% of starting body weight is associated with measurable improvements in blood pressure, blood glucose, and lipid levels (Wing et al., 2011). This reframing matters because chasing larger, faster losses often sets people up for the kind of rapid regain associated with very-low-calorie or highly restrictive short-term diets.

Rate of loss matters too. Very rapid weight loss (more than roughly 1–2 pounds per week for most people) is more often associated with muscle loss, gallstone risk, and rebound eating patterns, compared to a slower, steadier approach. Slower loss also gives the body more time to adjust rather than triggering the sharp compensatory hunger response described earlier (Sumithran et al., 2011).

Where medication fits in

The last several years have brought real advances in obesity pharmacotherapy, and it would be incomplete to write about sustainable weight loss without addressing them. GLP-1 receptor agonists — FDA-approved options include semaglutide (Wegovy) and the dual GIP/GLP-1 agonist tirzepatide (Zepbound) — have produced weight loss substantially larger than most prior medications in clinical trials.

In the STEP 1 trial, adults using semaglutide alongside lifestyle intervention lost an average of about 15% of body weight over 68 weeks, compared to roughly 2.4% in the placebo-plus-lifestyle group (Wilding et al., 2021). Tirzepatide has shown even larger average losses — up to around 20% at higher doses over 72 weeks in the SURMOUNT-1 trial (Jastreboff et al., 2022). These are meaningful results, and for people who have struggled with weight for years despite lifestyle efforts, they represent a legitimate option to discuss with a clinician.

Two caveats are important. First, these medications were studied alongside lifestyle counseling, not as a replacement for it — behavior change still matters for maximizing and sustaining results. Second, both trials found that a meaningful portion of the weight was regained after the medication was stopped, underscoring that these are generally long-term treatments for a chronic condition, not short courses (Wilding et al., 2021). We do not recommend compounded versions of these medications, which fall outside FDA approval and quality oversight; any use should involve an FDA-approved formulation prescribed and monitored by a licensed clinician.

What to do with this

Pick an eating pattern you can sustain, not necessarily the one that's trending. Whole foods, adequate protein, and a modest calorie deficit outperform any specific diet label over the long run (Sacks et al., 2009; Gardner et al., 2018).
Build in self-monitoring — regular weigh-ins, food logging, or a coaching check-in — since this is one of the more consistent predictors of long-term success (Wing et al., 2011).
Aim for gradual loss, roughly 1–2 pounds a week, and treat 5–10% of body weight as a genuinely meaningful goal rather than a disappointing one (Wing et al., 2011).
Plan for maintenance from day one. Because the body's hunger and metabolic signals shift after weight loss, expect to need an ongoing strategy — not a temporary diet with an end date (Sumithran et al., 2011; Fothergill et al., 2016).
If you're considering medication, ask your clinician about FDA-approved GLP-1 or GIP/GLP-1 options, how they'd fit alongside lifestyle changes, and what the plan would be for the long term.

This article is for general information and is not medical advice. Weight, metabolism, and health risk are influenced by many individual factors. Talk to your clinician before starting any weight-loss program or medication, especially if you have underlying health conditions.

References

Sacks, F. M., et al. (2009). Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. New England Journal of Medicine.
Sumithran, P., et al. (2011). Long-term persistence of hormonal adaptations to weight loss. New England Journal of Medicine.
Fothergill, E., et al. (2016). Persistent metabolic adaptation 6 years after "The Biggest Loser" competition. Obesity.
Wing, R. R., & Phelan, S. (2005). Long-term weight loss maintenance. American Journal of Clinical Nutrition.
Wing, R. R., et al. (2011). Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care.
Look AHEAD Research Group (2014). Eight-year weight losses with an intensive lifestyle intervention. Obesity.
Gardner, C. D., et al. (2018). Effect of low-fat vs low-carbohydrate diet on 12-month weight loss (DIETFITS). JAMA.
Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine.
Jastreboff, A. M., et al. (2022). Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine.

HealthNation publishes informational content, not medical advice. For diagnosis or treatment, talk to a licensed clinician. See our medical disclaimer.